Navan Stock Down From IPO: New $274M Stake Signals Conviction
Navan stock down from its IPO price has dropped sharply, but a major investor just built a substantial stake. Here’s ...
We compare high-return candidates for Roth IRA indexing, analyzing volatility, fees, and potential tax-free compounding effects.
28,037 articlesNavan stock down from its IPO price has dropped sharply, but a major investor just built a substantial stake. Here’s ...
When markets slump, two crypto giants throw up different signals. This guide breaks down the case for Bitcoin as the ...
One year into Lip-Bu Tan’s tenure, Intel trimmed costs, pushed 18A production forward, and rebuilt the balance sheet—...
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Archer Aviation faces a critical cash burn challenge as it works toward FAA certification and commercial revenues. Th...
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Strategy transferred 411.48 BTC to Coinbase on May 29, 2026, a tiny slice of its huge stake. The move sparks renewed ...
Tokenized treasuries moving onto the XRP Ledger are expanding rapidly, with massive on-chain volumes and a key JPMorg...
Small-cap stocks have staged a surprising comeback as the market navigates a higher-for-longer rate environment. Inve...
U.S. XRP ETF inflows remain near zero in mid-July as institutional appetite cools and on-chain activity moderates, ke...
Bitcoin and Ethereum start 2026 with steep losses, marking their worst year-to-date performance in a decade. Analysts...
A noted market analyst warns that Strategy’s aggressive Bitcoin purchases echo dot-com-era speculation, risking a ste...